dr. ellis on abemaciclib in hr-positive breast cancer
Published 6 years ago • 513 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
0:22
copy of dr. ellis on abemaciclib in hr-positive breast cancer
-
1:24
dr. ellis on adjuvant cdk4/6 inhibition in hr-positive breast cancer
-
7:09
abemaciclib for hr-positive metastatic breast cancer
-
1:52
dr. ellis on resistance to endocrine therapy in hr metastatic breast cancer
-
0:50
dr. ellis on immunotherapy in her2 breast cancer
-
1:25
dr. ellis on neoadjuvant endocrine therapy for breast cancer
-
4:45
abemaciclib monotherapy’s role in hr breast cancer
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
1:12
monarche: adjuvant abemaciclib in hr breast cancer
-
2:30
monarche: abemaciclib and adjuvant endocrine therapy for high-risk hr early breast cancer
-
5:04
abemaciclib fulvestrant at progression of hr mbc
-
1:41
dr. tolaney on activity with abemaciclib in patients with hr /her2– breast cancer
-
13:02
dr. matthew ellis on hormonal therapy before breast cancer surgery
-
3:26
emerging role of abemaciclib for hr advanced breast cancer
-
0:53
postmonarche: abemaciclib fulvestrant in hr /her2- mbc following cdk4/6i & endocrine therapy
-
6:15
abemaciclib with hormone therapy for hr mbc
-
0:58
dr. ellis on anticipated er /her2- breast cancer paradigms
-
0:20
copy of dr. ellis on the entrance of biosimilars into the field of oncology
-
3:09
dr mouabbi on the use of ribociclib vs abemaciclib in hr /her2– breast cancer